Make some medications more affordable by cutting one piece of red tape

Congress is being urged to pass the Biosimilar Red Tape Elimination Act to reduce medication costs by removing the costly interchangeability standard for biologics.

Summary aggregated from The Hill's public RSS feed. The full reporting belongs to The Hill — please read it on their site.